Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium. - Wikidata - wikimedia - TriplyDB

Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium.

Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium.

http://www.wikidata.org/entity/Q30566351

about

The human subject: an integrative animal model for 21(st) century heart failure research Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening The myocardial regenerative potential of three-dimensional engineered cardiac tissues composed of multiple human iPS cell-derived cardiovascular cell lineages.Signaling Pathways and Gene Regulatory Networks in Cardiomyocyte Differentiation Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues Combined biophysical and soluble factor modulation induces cardiomyocyte differentiation from human muscle derived stem cells Human iPSC-based cardiac microphysiological system for drug screening applications.Direct hydrogel encapsulation of pluripotent stem cells enables ontomimetic differentiation and growth of engineered human heart tissues.Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy Human Cardiac Tissue Engineering: From Pluripotent Stem Cells to Heart Repair.Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes.Anisotropic silk biomaterials containing cardiac extracellular matrix for cardiac tissue engineering.Prospects for In Vitro Myofilament Maturation in Stem Cell-Derived Cardiac Myocytes.Human Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy.Anisotropic engineered heart tissue made from laser-cut decellularized myocardium.Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair.Integrated Analysis of Contractile Kinetics, Force Generation, and Electrical Activity in Single Human Stem Cell-Derived Cardiomyocytes Myocardial Delivery of Lipidoid Nanoparticle Carrying modRNA Induces Rapid and Transient Expression Fibrous scaffolds for building hearts and heart parts.In vitro cardiac tissue models: Current status and future prospects.Biology of the cardiac myocyte in heart disease.Biomaterials for pluripotent stem cell engineering: From fate determination to vascularization.Non-cell autonomous cues for enhanced functionality of human embryonic stem cell-derived cardiomyocytes via maturation of sarcolemmal and mitochondrial KATP channels.Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells.Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes.Generating patient-specific induced pluripotent stem cells-derived cardiomyocytes for the treatment of cardiac diseases.Tissue Engineering Approaches in the Design of Healthy and Pathological In Vitro Tissue Models.Differential Sarcomere and Electrophysiological Maturation of Human iPSC-Derived Cardiac Myocytes in Monolayer vs. Aggregation-Based Differentiation Protocols.Pyrogallol, an absorbable microbial gallotannins-metabolite and mango polyphenols (Mangifera Indica L.) suppress breast cancer ductal carcinoma in situ proliferation in vitro.Modeling the Human Scarred Heart In Vitro: Toward New Tissue Engineered Models.Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model.Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening.Human iPSC-Derived Cardiomyocytes for Investigation of Disease Mechanisms and Therapeutic Strategies in Inherited Arrhythmia Syndromes: Strengths and Limitations.Real-Time Force and Frequency Analysis of Engineered Human Heart Tissue Derived from Induced Pluripotent Stem Cells Using Magnetic Sensing.Can the second law of thermodynamics hold in cell cultures?Modeling CVD in human pluripotent cells by genome editing.Mechanical Stress Conditioning and Electrical Stimulation Promote Contractility and Force Maturation of Induced Pluripotent Stem Cell-Derived Human Cardiac Tissue.Dynamic culture yields engineered myocardium with near-adult functional output.Machine Learning of Human Pluripotent Stem Cell-Derived Engineered Cardiac Tissue Contractility for Automated Drug Classification.

P2860

Q26778484-831F43A7-FAF0-45A5-A8AF-6A8990E660DC Q26799470-77CE8A85-F300-488D-B92B-5B71F0FCE247 Q27325259-55B67454-F83E-4709-B860-2E2530166BA4 Q28087290-269F0435-C2AA-4D60-8E86-5E08490BB8C6 Q28550738-A9939D87-5207-4062-A053-BE177B45A681 Q30591797-4FABE443-17A6-42E8-9CEE-BB0DE37CA4B8 Q30625616-D7DA03A2-AF94-4C83-8BB4-1F8D001EBDBE Q30731784-71A873F7-3D24-4B2C-B423-88DE5BD3B686 Q31056955-FDAFE5F6-B54F-4294-AF60-4D62BEA045F8 Q34947905-DA68A370-B980-4C86-9472-27935C042601 Q35414785-2116237D-EB40-4DA4-9B8F-F27CDC594E92 Q35562754-BB969CBE-F8F8-49BF-B901-E34EB8E5290D Q35724421-6352E055-0F01-4682-AA39-3D307C7BE4CB Q35897783-4BE4E8AC-CB0F-47D8-B1E9-144D2F68565D Q36116195-13A880CB-376E-4E27-9C87-F4B04EB6FF32 Q36279078-9FCF0374-112F-457D-819C-9C656FF7046E Q36379865-46FBB09A-4805-4CE0-99D6-9D8A04EC11A7 Q36582843-3423F9E9-6F7E-454F-A424-202908C0D48A Q36728608-1F7A4C64-678A-49BE-A172-5503E2C6502B Q36801550-A1497723-B9BF-42E1-93EB-BAA52B2BB79E Q37095254-DD25950E-A319-4965-8130-746FDDD009DA Q37103251-AFB9BA91-C034-473F-95FD-E3BB468AED76 Q37291421-70AC832A-801A-42A6-B2C1-B7208079990B Q37613893-66264EF7-734A-4E96-82C5-E6F0910604FF Q38182186-0B45BC7D-DB5C-4F1E-A56B-711D7DC25896 Q38541742-66167405-58FA-40A7-B278-828C52C1FB78 Q38644027-CCC8B615-F60C-4C04-8F3D-AD21609DC492 Q38740489-2460B3C8-5149-45CE-B5E4-F916066E67F1 Q38753801-C041909D-88E8-4C90-93AB-A2C8AFABC3F1 Q38788603-09C5C507-1636-4762-85B8-A7F389F96AEF Q38819976-332B86E6-C193-422C-BC5E-65A9AA83C110 Q38842308-91C13973-E721-4418-BFAD-AF1C7586949D Q39050993-95373F8F-B577-497C-BC2B-258280E62DCB Q39443185-2C76FA75-A306-4C5E-8BDF-A4C01E197993 Q41573786-F71CC2C4-AE6F-4B64-8F31-3CA59A932DB5 Q42425377-60AB432D-8A41-4A2D-9605-3DA3029D44AF Q42692293-9F4CD67C-D31F-4292-8BDE-03F449B3F817 Q43276365-3FB67AD3-8CDF-488C-9159-2B80D42A84A0 Q45914075-4E80828A-01C1-46C7-A928-70E63DD66280 Q45944962-B1A2507A-8015-4E47-9852-4D9CAC805A09

P2860

Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium.

http://www.wikidata.org/entity/Q30566351

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Advancing functional engineere ...... cal model of human myocardium.

@ast

Advancing functional engineere ...... cal model of human myocardium.

@en

type

label

Advancing functional engineere ...... cal model of human myocardium.

@ast

Advancing functional engineere ...... cal model of human myocardium.

@en

prefLabel

Advancing functional engineere ...... cal model of human myocardium.

@ast

Advancing functional engineere ...... cal model of human myocardium.

@en

P1433

Q30566351-1880ABBC-D762-4956-9378-5D0CC52013A3

P1476

Q30566351-556A732E-55EF-4EDD-ABF4-6C71F8B7A334

P2093

Q30566351-16C7E015-355C-4D6A-921D-20AD6518D3C0

Q30566351-28F1C073-B190-4C7A-A2B0-18EA5B690ECD

Q30566351-3021EC81-371D-4D6F-9D4E-022BBBC1736C

Q30566351-323167F1-645A-4840-9289-588946C2D327

Q30566351-3998594B-CA58-49E8-BBB1-1651CCC61A5D

Q30566351-6A31254B-CBB2-4373-A555-3F47B629BDF1

Q30566351-7F648957-ACC0-4C6F-B641-CA14866EFFF7

Q30566351-8BD50830-5518-4FC8-8B7E-2C4A4037DE33

Q30566351-B934E9D1-BFB1-41C3-9458-C664AD5A324F

Q30566351-BF40DA74-9D2D-435F-90EA-74F9E2C181E5

P2860

Q30566351-003D1646-86D9-485B-AD4F-4621962F4DDB

Q30566351-0D2CA6C4-122D-41C4-A22F-D85F1C9945AF

Q30566351-0E62BE39-D8B9-43F1-B90D-7CEC1D1E958B

Q30566351-11965890-A3A4-4AEC-8CB0-3A5D3A05E999

Q30566351-169AB38D-8399-43D8-BC29-0259C8E42D0E

Q30566351-18584FF4-263C-4301-8724-4B3DF91A7F55

Q30566351-19AE095B-A2F5-48FA-B303-0473092CD7DD

Q30566351-1D086AB7-6615-4CF0-9257-D575930D2CF9

Q30566351-3E1D70B1-F8D6-4C79-9E33-0252BC3E3233

Q30566351-4CE55C98-EFEB-4420-8EB8-A78688B41030

P304

Q30566351-5DC053A2-781D-4DFE-BBC8-7BD509A05184

P31

Q30566351-8C39AB40-EB00-4B3D-B8A9-D6C647C47D8F

P356

Q30566351-9AF7DFC7-72DC-4026-B58A-E212D6D6A278

P407

Q30566351-9187A5ED-E2E2-4F4F-8DCE-C5C1B95641DC

P433

Q30566351-9FEE4C0A-E6EA-4701-9FEB-8A177168DC84

P478

Q30566351-9912AEC4-23C3-480D-86BA-48AFCD84DACB

P50

Q30566351-AD31936C-4515-461C-8CC3-D8DAF98F0DF8

P577

Q30566351-41EF851C-FE23-47DD-A2EE-5AC55F8F9297

P5875

Q30566351-86D8C377-645B-426E-995D-0F86CE9C981E

P698

Q30566351-0A17F0C2-25C9-4BEA-8328-8AEA81804F42

P932

Q30566351-91D948D9-0C7D-4D20-82CE-D334C3D0BA00

P356

P1433

P1476

Advancing functional engineere ...... ical model of human myocardium

@en

P2093

Chaoqin Xie

http://www.w3.org/2001/XMLSchema#string

Fadi G Akar

http://www.w3.org/2001/XMLSchema#string

Grant Senyei

http://www.w3.org/2001/XMLSchema#string

Gregory W Serrao

http://www.w3.org/2001/XMLSchema#string

Ioannis Karakikes

http://www.w3.org/2001/XMLSchema#string

Irene C Turnbull

http://www.w3.org/2001/XMLSchema#string

Jia-Jye Lee

http://www.w3.org/2001/XMLSchema#string

Kevin D Costa

http://www.w3.org/2001/XMLSchema#string

Peter Backeris

http://www.w3.org/2001/XMLSchema#string

Roger J Hajjar

http://www.w3.org/2001/XMLSchema#string

P2860

Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology

Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes

Growth of engineered human myocardium with mechanical loading and vascular coculture

Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue.

Spatiotemporal relation between gap junctions and fascia adherens junctions during postnatal development of human ventricular myocardium

Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating

Parthenogenetic stem cells for tissue-engineered heart repair.

Small molecule-mediated directed differentiation of human embryonic stem cells toward ventricular cardiomyocytes.

Tissue engineering of vascularized cardiac muscle from human embryonic stem cells.

Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue.

P304

644-654

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1096/FJ.13-228007

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Sébastien Hulot

P577

2013-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258204555

http://www.w3.org/2001/XMLSchema#string

P698

24174427

http://www.w3.org/2001/XMLSchema#string

P932

3898643

http://www.w3.org/2001/XMLSchema#string